“The Effect of Long-Acting Beta-2 Agonist Monotherapy and Long-Acting Anticholinergic Monotherapy to Quality-of-Life in Group B Stable COPD Patients”. Jurnal Respirologi Indonesia 42, no. 4 (September 29, 2022): 277–281. Accessed July 4, 2025. http://www.jurnalrespirologi.org/index.php/jri/article/view/370.